{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Expanding Precision Oncology With Targeted Immunotherapy","description":" Dr. Pedro Barata and Dr. Bridget Keenan discuss the   innovative bioengineering allowing clinicians to target historically &quot;immune-cold&quot; tumors, the logistical evolution of bringing bispecific therapies safely into outpatient community clinics, and the complex future of predictive biomarkers and resistance mechanisms.  LINK TO FULL TRANSCRIPT ","author_name":"ASCO Education","author_url":"http:\/\/sites.libsyn.com\/97740","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41539550\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/00b087\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/41539550"}